Reducing Postoperative Recurrence of Early‐Stage Hepatocellular Carcinoma by a Wound‐Targeted Nanodrug-Reference-Cited by-同舟云学术

Reducing Postoperative Recurrence of Early‐Stage Hepatocellular Carcinoma by a Wound‐Targeted Nanodrug

Published:2022-05-07 Issue:20 Volume:9 Page:2200477
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

li Bozhao¹²,Zhang Xiuping³,Wu Zhouliang¹,Chu Tianjiao¹²,Yang Zhenlin⁴,Xu Shuai³,Wu Suying¹⁵,Qie Yunkai¹,Lu Zefang¹⁵,Qi Feilong¹,Hu Minggen³,Zhao Guodong³,Wei Jingyan²,Zhao Yuliang¹⁵⁶⁷,Nie Guangjun¹⁵⁶⁷,Meng Huan¹⁵,Liu Rong³,Li Suping¹⁵⁶⁷^ORCID

Affiliation:

1. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center for Excellence in Nanoscience National Center for Nanoscience and Technology Beijing 100190 China

2. College of Pharmaceutical Science Jilin University Changchun 130021 China

3. Faculty of Hepato‐Biliary‐Pancreatic Surgery Chinese People's Liberation Army (PLA) General Hospital Institute of Hepatobiliary Surgery of Chinese PLA Key Laboratory of Digital Hepatobiliary Surgery PLA Beijing 100853 China

4. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 China

5. University of Chinese Academy of Sciences Beijing 100049 China

6. Center of Materials Science and Optoelectronics Engineering University of Chinese Academy of Sciences Beijing 100049 China

7. GBA Research Innovation Institute for Nanotechnology Guangzhou 510530 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202200477

Reference27 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma

3. Advances in drug delivery for post-surgical cancer treatment

4. Advances in local and systemic drug delivery systems for post-surgical cancer treatment

5. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancer;Journal of Colloid and Interface Science;2024-10

2. Decitabine-based nanoparticles for enhanced immunotherapy of hepatocellular carcinoma via DNA hypermethylation reversal;Chemical Engineering Journal;2024-07

3. Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma;Journal of Nanobiotechnology;2024-05-12

4. Estimating eGFR using serum creatinine or cystatin C in healthy Vietnamese population;Medicine;2024-05-03

5. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments;Medicine;2024-05-03